Pregnancy in patients with underlying renal disease;Maladies rénales et grossesse

Revue Medicale Suisse

Volumn 3, Issue 101, 2007, Pages 588-595

  Golshayan, Déla ^a   Mathieu, Claudine ^a   Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CHLORAMBUCIL; CIPROFLOXACIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; METHYLDOPA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORFLOXACIN; OFLOXACIN; PENICILLIN G; PREDNISOLONE; QUINOLONE DERIVATIVE; RAPAMYCIN; SULFANILAMIDE; TACROLIMUS; TRIMETHOPRIM;

CHRONIC KIDNEY FAILURE; CONCEPTION; DISEASE SEVERITY; FEMALE FERTILITY; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BLOOD FLOW; KIDNEY TRANSPLANTATION; PREGNANCY OUTCOME; PROTEINURIA; REVIEW; RISK FACTOR; SURVIVAL; SYSTEMIC DISEASE; URINARY TRACT INFECTION;

FEMALE; HUMANS; KIDNEY DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33947592139     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. * Lindheimer MD, Grunfeld JP, Davison JM. Renal disorders. In: Medical disorders during pregnancy. Baron WM, Lindheimer MD (editors). Chicago, USA: Mosby Inc., 2000.
2. ** Davison JM. Renal disorders in pregnancy. Curr Opin Obstet Gynecol. 2001;13:109-14.
3. Baylis C, Reckelhoff JF. Renal haemodynamics in normal and hypertensive pregnancy: Lessons from micropuncture. Am J Kidney Dis 1991;17:98-104.
4. Danielson LA, Sherwood OD, Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 1999;103:525-33.
5. Baylis C. Relaxin may be the «elusive» renal vasodilatory agent of normal pregnancy. Am J Kidney Dis 1999;34:1142-5.
6. Conrad KP, Gandley RE, Ogawa T, Nakanishi S, Danielson LA. Endothelin mediates renal vasodilatation and hyperfiltration during pregnancy in chronically instrumented conscious rats. Am J Physiol 1999;276:F767-76.
7. Davison J, Dunlop W. Renal hemodynamics and tubular function in normal human pregnancy. Kidney Int 1980;18:152-61.
8. Brown MA. Urinary tract dilatation in pregnancy. Am J Obstet Gynecol 1990;164:642-3.
9. Palmer B. Sexual dysfunction in uraemia. J Am Soc Nephrol 1999;10:1366.
10. Packham D, Fairley KF. Renal biopsy: Indications and complications in pregnancy. Br J Obstet Gynaecol 1987;94:935-9.
11. Brown MA, Reiter L, Whitworth JA. Hypertension in pregnancy: The incidence of underlying renal disease and essential hypertension. Am J Kidney Dis 1994;24:883-7.
12. ** Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996;335:226-32.
13. ** Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999;33:235-52.
14. * Bar J, Ben-Rafael Z, Padoa A, et al. Prediction of pregnancy outcome in subgroups of women with renal disease. Clin Nephrol 2000;53:437-44.
15. Davison JM. Effect of pregnancy on long-term function of renal allografts. Am J Kidney Dis 1992;19:167-72.
16. ** Armenti VT, Moritz MJ, Radomski JS, Davison JM. Pregnancy and transplantation. Graft 2000;3:59-63.
17. Abe S, Amagasaki Y, Konishi K, et al. The influence of antecedent renal disease on pregnancy. Am J Obstet Gynecol 1985;153:508-14.
18. Katz A, Davidson J, Hayslett J, Singson E, Lindleimer M. Pregnancy in women with kidney disease. Kidney Int 1980;18:192-206.
19. * Surian M, Imbasciati E, Cosci P, et al. Glomerular disease in pregnancy. A study of 123 pregnancies in patients with primary and secondary glomerular diseases. Nephron 1984;36:101-5.
20. * Jungers P, Houillier P, Forget D, et al. Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet 1995;346:1122-4.
21. e ed. Genève: Editions Med Hyg, 2006.
22. * Armenti VT, Moritz MJ, Cardonick EH, Davison JM. Immunosuppression in pregnancy: Choices for infant and maternal health. Drugs 2002;62:2361-75.
23. Sifontis NM, Coscia LA, Constantinescu S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006;82:1698-702.
24. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92.
25. Armenti VT, Ahlswede KM, Ahlswede BA, et al. National transplantation pregnancy registry - outcomes of 154 pregnancies in cyclosporine-treated female kidney-transplant recipients. Transplantation 1994;57:502-6.
26. Ferrier C, North RA, Becker G, et al. Uterine artery waveform as a predictor of pregnancy outcome in women with underlying renal disease. Clin Nephrol 1994;42:362-8.
27. Beaufils M, Uzan S, Donslmoni R, et al. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985;1:840-2.
28. Kincaid-Smith P, North RA, Fairley KF, Kloss M, Ihle BU. Prevention of pre-eclampsia in high risk women with renal disease: A prospective randomised trial of heparin and dipyridamole. Nephrology 1995;1:297-300.
29. * Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of preeclampsia and its consequences: Systematic review. BMJ 2001;322:329-33.